Patients with acute liver failure (ALF) or acute-on-chronic liver failure (ACLF) are at high risk of bleeding with ...

Background and objectives Patients with acute liver failure (ALF) or acute-on-chronic liver failure (ACLF) are at high risk ...

Imatinib mesylate has anti-inflammatory properties, because it is a specific and potent inhibitor of several protein tyrosine kinases. Paniagua et al. have investigated imatinib's mechanism of ...

Researchers have reported a potential oral treatment for Alzheimer’s disease that slowed its progression over a period of at least 18 months. Developed by Singaporean company TauRx Pharmaceutics Ltd, ...

Patients with acute liver failure (ALF) or acute-on-chronic liver failure (ACLF) are at high risk of bleeding with traditional artificial liver ...